Autor Título Original / Colaboración Selecciona una opción Original Colaboración Año Selecciona un año2015201620172018201920202021202220232024 Cuartil Selecciona un cuartilD1Q1Q2Q3Q4 Tipo Selecciona un tipo#N/DArticleArtículoBook ChapterBook ReviewClinical TrialCommentaryCorrectionData PaperEditorialEditorial MaterialLetterProceedings PaperReprintReview Revista Three-year interim results of overall and progression-free survival in a cohort of patients with prostate cancer (GESCAP group) Autores: Cozar, JM; Minana, B; Gomez-Veiga, F; Rodriguez-Antolin, A Factors related to early castration resistance in metastatic prostate cancer. Results from the National Prostate Cancer Registry in Spain Autores: Lloret-Dura, MA; Panach-Navarrete, J; Martinez-Jabaloyas, JM; Valls-Gonzalez, L; Cozar-Olmo, JM; Minana-Lopez, B; Gomez-Veiga, F; Rodriguez-Antolin, A The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses Autores: Aptsiauri, N; Ruiz-Cabello, F; Garrido, F Genetic markers a landscape in prostate cancer Autores: Cozar, JM; Robles-Fernandez, I; Martinez-Gonzalez, LJ; Pascual-Geler, M; Rodriguez-Martinez, A; Serrano, MJ; Lorente, JA; Alvarez-Cubero, MJ MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy Autores: Romero, I; Garrido, C; Algarra, I; Chamorro, V; Collado, A; Garrido, F; Garcia-Lora, AM MHC Class-I Loss and Cancer Immune Escape Concluding Remarks Autores: Garrido, F Cancer immune escape: MHC expression in primary tumours versus metastases Autores: Garrido, F; Aptsiauri, N < 1 2 … 1.458 1.459 1.460 … 1.504 1.505 >
